Clinical Trials Browser

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT05105867 2023-05-10

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies

Phase EARLY_PHASE1 Unknown

15 enrolled

Lymphoid

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

Clinical Trials

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

ARTIHCC

BELLA

BORTEM-17

Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids

PREVENT-2

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph Nodes

Prolgo-HL

DLI-Boost

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

V-CHANCE

Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum

Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence

DMIA

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening

T1 Squamous Cell Carcinomas of the Lip

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

Abdominal or Transanal TME for Rectal Cancer Therapy

CRU3

REDUCE

CORE1

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

TvT CAR7

TaRRGET

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

FLICOR

GI-HPVT-01

DaRT-V

POTERE

ANCHOR2

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies